Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 Magnachip Semiconductor (NYSE: MX) Q12022Earnings Materials May 3, 2022
Magnachip Semiconductor (NYSE: MX)
Q12022Earnings Materials
May 3, 20222Forward -Looking Statements
Information inthispresentation regarding Magnachip’s forecasts, business outlook, expectations andbeliefs areforward -looking statements within themeaning ofthe
Private Securities Litigation Reform Actof1995 that involve risks and uncertainties .Allforward -looking statements included orincorporated byreference inthis
presentation, including expectations about estimated historical orfuture operating results andfinancial performance, business strategies, outlook andplans, including
second quarter 2022 revenue andgross profit margin expectations, future growth andrevenue opportunities from new andexisting products andcustomers, theimpact
oftheCOVID -19pandemic ortheemergence ofvarious variants ofthevirus, escalated trade tensions andsupply constraints onMagnachip’s second quarter 2022 and
future operating results, andthetiming andextent offuture revenue contributions byourproducts andbusinesses, arebased upon information available toMagnachip
asofthedate ofthispresentation and theaccompanying press release, which may change, and weassume noobligation toupdate any such forward -looking
statements .These statements arenotguarantees offuture performance, andactual results could differ materially from ourcurrent expectations .Factors thatcould
cause orcontribute tosuch differences include, among others :theimpact ofchanges inmacroeconomic and/or general economic conditions, including those caused by
orrelated totheCOVID -19pandemic ortheemergence ofvarious variants ofthevirus, other outbreaks ofdisease, theRussia -Ukraine crisis, recessions, economic
instability orcivil unrest ;manufacturing capacity constraints orsupply chain disruptions that may impact ourability todeliver ourproducts oraffect theprice of
components, which may lead toanincrease inourcosts, aswell asimpacting demand forourproducts from customers who aresimilarly affected bysuch capacity
constraints ordisruptions ;theimpact ofcompetitive products and pricing ;timely design acceptance byourcustomers ;timely introduction ofnew products and
technologies ;ability toramp new products intovolume production ;industry wide shifts insupply anddemand forsemiconductor products ;industry and/or company
overcapacity orsupply constraints ;effective and cost efficient utilization ofmanufacturing capacity ;financial stability inforeign markets and theimpact offoreign
exchange rates ;unanticipated costs andexpenses ortheinability toidentify expenses which canbeeliminated ;compliance withU.S.andinternational trade andexport
laws andregulations byus,ourcustomers andourdistributors, including those related totheRussia -Ukraine crisis ;change orratification oflocal orinternational laws
andregulations, including those related toenvironment, health andsafety ;public health issues, including theCOVID -19pandemic ortheemergence ofvarious variants
Preview truncated — download the full document for the complete content.
investor_presentation
10 Pages
investor_presentation
46 Pages
Inhibrx